The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Severe Mental Illness and Risk of Cardiovascular Disease
Abstract
countries, and will remain so during the 21st century.1 In 2004, CVD was listed as the underlying cause of death in 871 517 of all 2 398 000 deaths (36.3%), or 1 of every 2.8 deaths in the United States, with CHD accounting for 52% and stroke for 17%.2 During the past several decades, CVD mortality has markedly declined in the United States, from more than 50 % to approximately 36 % as the underlying cause of death. Recent data suggest that the decline is largely due to improved diagnosis and treatment rather than to major successes in primary prevention. In contrast, patients with severe mental illnesses, such as schizophre-nia, bipolar disorder, and depression that together affect 5% to 10 % of the US population,3 lose 25 or more years of life expectancy, with the majority of the excess premature deaths due to CVD, not suicide.4 In this Commentary, we summarize disparities in CVD mortality and prevention efforts comparing the general population and individuals with severe mental illnesses and suggest the urgent need for new paradigms. In the general US population, cigarette consumption has been the leading avoidable cause of all premature deaths, with the amount currently smoked representing a keymea-sure of risk.5 Smoking rates in the general population have declined from more than 50 % in the 1950s to approxi-mately 25 % at present.5 However, among patients with di-agnosable mental illness, 50 % to 80 % are smokers and con-sume 34 % to 44 % of all cigarettes in the United States.6 Although patients with severe mental illness are overrep-resented in state programs likeMedicaid, some states do not cover any form of tobacco-dependence treatment.7 In ad-dition, only a few states cover all treatments recommended in theUSPreventive Services Task Force guidelines on smok-ing cessation.7 Moreover, some states that cover tobacco-dependence treatment require cost sharing, a serious dis-incentive for disabled patients with fixed income.7
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several studies have found that risk factors for cardiovascular disorders were more common in patients with severe mental disorders (Birkenaes et al. 2007, Newcomer & Hennekens 2007) than in patients without such disorders.”
From Excess early mortality in schizophrenia. (2014) · cites this paper as Newcomer & Hennekens 2007
Citations
Cites
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
Rosamond, W., Flegal, K., Friday, G., Furie, K., Go, A., Greenlund, K., Haase, N., Ho, M., Howard, V., Kissela, B., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.179918 · Cited by 3,277
Mental Health: A Report of the Surgeon General
United States. Public Health Service. Office of the Surgeon General (1999) · PsycEXTRA Dataset · doi:10.1037/e636982009-001 · Cited by 3,105
Lichtenstein, A. H., Appel, L. J., Brands, M., Carnethon, M., Daniels, S., Franch, H. A., Franklin, B., Kris-Etherton, P., Harris, W. S., Howard, B., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.176158 · Cited by 2,705
Park, Y.-W., Zhu, S., Palaniappan, L., Heshka, S., Carnethon, M. R., & Heymsfield, S. B. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.4.427 · Cited by 2,074
Increasing Prevalence of the Metabolic Syndrome Among U.S. Adults
Ford, E. S., Giles, W. H., & Mokdad, A. H. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2444 · Cited by 1,488
Second-Generation (Atypical) Antipsychotics and Metabolic Effects
Newcomer, J. W. (2005) · CNS Drugs · doi:10.2165/00023210-200519001-00001 · Cited by 1,352
Self-citation(2006) · Europe PMC (PubMed Central) · Cited by 1,299
Cited by
Sorted by citations
Items 101–200 of 433
Physical activity interventions: an essential component in recovery from mental illness
Rosenbaum, S., Tiedemann, A., Ward, P. B., Curtis, J., & Sherrington, C. (2014) · British Journal of Sports Medicine · doi:10.1136/bjsports-2014-094314 · Cited by 44
Bochicchio, L. A., Stefančić, A., Gurdak, K., Swarbrick, M. A., & Cabassa, L. J. (2018) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1007/s10488-018-0914-6 · Cited by 41
Cabassa, L. J., Humensky, J. L., Druss, B. G., Lewis‐Fernández, R., Gomes, A. P., Wang, S., & Blanco, C. (2013) · Medical Care · doi:10.1097/mlr.0b013e31828dbb19 · Cited by 45
Cahoon, E. K., McGinty, E. E., Ford, D. E., & Daumit, G. L. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-37 · Cited by 42
High Rates of Obstructive Sleep Apnea Symptoms Among Patients With Schizophrenia
Annamalai, A., Palmese, L. B., Chwastiak, L., Srihari, V. H., & Tek, C. (2014) · Psychosomatics · doi:10.1016/j.psym.2014.02.009 · Cited by 42
By what molecular mechanisms do social determinants impact cardiometabolic risk?
Baumer, Y., Pita, M. A., Baez, A. S., Ortiz-Whittingham, L. R., Cintron, M., Rose, R., Gray, V. C., Baah, F. O., & Powell‐Wiley, T. M. (2023) · Clinical Science · doi:10.1042/cs20220304 · Cited by 40
Kang, R., Wu, Y., Li, Z., Jiang, J. H., Gao, Q., Yu, Y., Gao, K., Yan, Y., & He, Y. L. (2016) · Psychopathology · doi:10.1159/000448195 · Cited by 39
Tek, C., Ratliff, J. C., Reutenauer, E. L., Ganguli, R., & O'Malley, S. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000192 · Cited by 39
Effects of psychopharmacological treatment with antipsychotic drugs on the vascular system
Kahl, K. G., Westhoff‐Bleck, M., & Krüger, T. H. C. (2017) · Vascular Pharmacology · doi:10.1016/j.vph.2017.09.001 · Cited by 40
Cardiovascular Safety of Psychiatric Agents: A Cautionary Tale
Manolis, T. A., Manolis, A. S., & Manolis, A. S. (2018) · Angiology · doi:10.1177/0003319718780145 · Cited by 39
Metabolic Risk Status and Second-Generation Antipsychotic Drug Selection
Morrato, E. H., Cuffel, B. J., Newcomer, J. W., Lombardo, I., Kamat, S., & Barron, J. O. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31819294cb · Cited by 38
Self-citationMcGinty, E. E., Presskreischer, R., Breslau, J. A., Brown, J. D., Domino, M. E., Druss, B. G., Horvitz-Lennon, M. V., Murphy, K. A., Pincus, H. A., & Daumit, G. L. (2021) · Psychiatric Services · doi:10.1176/appi.ps.202000768 · Cited by 36
Management of Atypical Antipsychotic Drug‐Induced Weight Gain: Focus on Metformin
Miller, L. J. (2009) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.29.6.725 · Cited by 37
Watkins, K. E., Paddock, S. M., Hudson, T. J., Ounpraseuth, S., Schrader, A. M., Hepner, K. A., & Sullivan, G. (2016) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2016.06.001 · Cited by 36
McGinty, E. E., Kennedy‐Hendricks, A., Linden, S., Pessar, S. C., Stone, E. M., & Daumit, G. L. (2017) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2017.12.003 · Cited by 36
Antipsychotics and Metabolics in the Post-CATIE Era
Meyer, J. M. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_45 · Cited by 36
Subramaniam, M., Abdin, E., Picco, L., Vaingankar, J. A., & Chong, S. A. (2014) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2014.03.002 · Cited by 35
Strassnig, M., Cornacchio, D., Harvey, P. D., Kotov, R., Fochtmann, L. J., & Bromet, E. J. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.07.011 · Cited by 35
Barry, C. L., Stuart, E. A., Donohue, J. M., Greenfield, S. F., Kouri, E. M., Duckworth, K. S., Song, Z., Mechanic, R. E., Chernew, M. E., & Huskamp, H. A. (2015) · Health Affairs · doi:10.1377/hlthaff.2015.0685 · Cited by 35
Ebdrup, B. H., Knop, F. K., Ishøy, P. L., Rostrup, E., Fagerlund, B., Lublin, H., & Glenthøj, B. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-92 · Cited by 34
Kemp, D. E., Calabrese, J. R., Tran, Q.-V., Pikalov, A., Eudicone, J. M., & Baker, R. A. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05159gre · Cited by 34
Antipsychotics and the microbiota
Chen, A., Park, T. Y., Li, K. J., & DeLisi, L. E. (2020) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000594 · Cited by 34
Post, R. M., Altshuler, L. L., Kupka, R., McElroy, S. L., Frye, M. A., Rowe, M., Grunze, H., Suppes, T. M., Keck, P. E., Leverich, G. S., et al. (2015) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.14080204 · Cited by 34
Kihal, W., Padilla, C. M., Lalloué, B., Rougier, C., Defrance, J., Zmirou‐Navier, D., & Deguen, S. (2013) · Environmental Health · doi:10.1186/1476-069x-12-109 · Cited by 33
Lin, C., Chung, C., Chen, L., & Chien, W.-C. (2019) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2019.10.003 · Cited by 35
Gohlke, J. M. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2012.00062 · Cited by 32
Premature Mortality Among People with Mental Illness: Advocacy in Academic Psychiatry
Roberts, L. W., Louie, A. K., Guerrero, A. P. S., Balon, R., Beresin, E. V., Brenner, A. M., & Coverdale, J. (2017) · Academic Psychiatry · doi:10.1007/s40596-017-0738-9 · Cited by 35
Positionspapier zur Bedeutung psychosozialer Faktoren in der Kardiologie
Ladwig, K., Lederbogen, F., Albus, C., Angermann, C., Borggrefe, M., Fischer, D., Fritzsche, K., Haass, M., Jordan, J., Jünger, J., et al. (2013) · Der Kardiologe · doi:10.1007/s12181-012-0478-8 · Cited by 32
TRIVEDI, R. B., Post, E. P., Piegari, R. I., Simonetti, J. A., Boyko, E. J., Asch, S. M., Mori, A. M., Arnow, B. A., Fihn, S. D., Nelson, K. M., et al. (2019) · Journal of General Internal Medicine · doi:10.1007/s11606-019-05307-w · Cited by 32
Thompson, A. D., Hetrick, S. E., Álvarez‐Jiménez, M., Parker, A. G., Willet, M. R., Hughes, F., Gariup, M., Gomez, D. L., & McGorry, P. D. (2011) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048674.2011.595370 · Cited by 33
Ho, R., Au-Yeung, F. S. W., Lo, P. H. Y., Law, K. Y., Wong, K. O. K., Cheung, I. K. M., & Ng, S. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/923925 · Cited by 32
Nunes, D., Eskinazi, B., Rockett, F. C., Delgado, V. B., & Perry, I. D. S. (2013) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2013.07.001 · Cited by 31
Hartung, D. M., Low, A., Jindai, K., Mansoor, D., Judge, M., Mendelson, A., Kansagara, D. L., Motu’apuaka, M. L., Freeman, M., & Kondo, K. K. (2016) · Psychosomatics · doi:10.1016/j.psym.2016.09.009 · Cited by 31
Callaghan, R. C., Boire, M. D., Lazo, R. G., McKenzie, K. J., & Cohn, T. A. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.07.018 · Cited by 31
Kho, A., Daumit, G. L., Truesdale, K. P., Brown, A. F., Kilbourne, A. M., Ladapo, J. A., Wali, S., Cicutto, L. C., Matthews, A. K., Smith, J. D., et al. (2022) · Health Services Research · doi:10.1111/1475-6773.13983 · Cited by 30
Sajatovic, M., Forester, B. P., Gildengers, A. G., & Mulsant, B. H. (2013) · Neuropsychiatry · doi:10.2217/npy.13.78 · Cited by 32
Forensic autopsies in a naturalistic setting in Norway: Autopsy rates and toxicological findings
Frost, J., Slørdal, L., Vege, Å., & Nordrum, I. S. (2012) · Forensic Science International · doi:10.1016/j.forsciint.2012.10.023 · Cited by 30
Mental health nurses’ diabetes care skills – a training needs analysis
Nash, M. (2009) · British Journal of Nursing · doi:10.12968/bjon.2009.18.10.42472 · Cited by 30
New Paradigms of Old Psychedelics in Schizophrenia
Mahmood, D., Alenezi, S. K., Anwar, M. J., Azam, F., Qureshi, K. A., & Jaremko, M. (2022) · Pharmaceuticals · doi:10.3390/ph15050640 · Cited by 29
Clinical pearls for the monitoring and treatment of antipsychotic induced metabolic syndrome
DeJongh, B. M. (2021) · Mental Health Clinician · doi:10.9740/mhc.2021.11.311 · Cited by 29
Using Exercise to Treat Patients with Severe Mental Illness: How and Why?
Tetlie, T., Heimsnes, M. C., & Almvik, R. (2009) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20090201-14 · Cited by 29
Using Patient-facing Kiosks to Support Quality Improvement at Mental Health Clinics
Cohen, A. N., Chinman, M., Hamilton, A. B., Whelan, F., & Young, A. S. (2013) · Medical Care · doi:10.1097/mlr.0b013e31827da859 · Cited by 29
Double jeopardy in the United States: Early onset bipolar disorder and treatment delay
Post, R. M., Altshuler, L. L., Kupka, R., McElroy, S. L., Frye, M. A., Rowe, M., Grunze, H., Suppes, T. M., Keck, P. E., & Nolen, W. A. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113274 · Cited by 28
Lifestyles and Cardiovascular Risk in Individuals With Functional Psychoses
Fusar‐Poli, P., Marco, L. D., Cavallin, F., Bertorello, A., Nicolasi, M., & Politi, P. (2009) · Perspectives In Psychiatric Care · doi:10.1111/j.1744-6163.2009.00202.x · Cited by 28
Newcomer, J. W., Meyer, J. S., Baker, R. D., Eudicone, J. M., PIKALOV, A., Vester-Blokland, E., McQuade, R. D., CRANDALL, D. T., CARSON, W., & MARCUS, R. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.09.002 · Cited by 28
Self-citationAntipsychotic drugs: sudden cardiac death among elderly patients.
Narang, P., El-Refai, M., Parlapalli, R. S., Danilov, L., Manda, S., Kaur, G., & Lippmann, S. (2010) · PubMed Central · Cited by 28
Chalfoun, C., Karelis, A. D., Stip, É., & Abdel‐Baki, A. (2015) · Journal of Sports Sciences · doi:10.1080/02640414.2015.1119875 · Cited by 29
Rasmussen, H., Ebdrup, B. H., Oranje, B., Pinborg, L. H., Knudsen, G. M., & Glenthoj, B. Y. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000777 · Cited by 27
Rubin, E. H., & Zorumski, C. F. (2012) · Academic Medicine · doi:10.1097/acm.0b013e3182441697 · Cited by 25
Morrato, E. H., Druss, B. G., Hartung, D. M., Valuck, R. J., Thomas, D. S. K., Allen, R. R., Campagna, E. J., & Newcomer, J. W. (2010) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2062 · Cited by 24
Self-citationNewcomer, J. W., Eriksson, H., Zhang, P., Weiller, E., & Weiss, C. (2018) · Current Medical Research and Opinion · doi:10.1080/03007995.2018.1498779 · Cited by 25
Self-citationPoor health behaviour and reduced quality of life of people treated with psychotropic drugs
Kopp, M., Fleischhacker, W. W., Stürz, K., Ruedl, G., Kumnig, M., & Rumpold, G. (2011) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1190 · Cited by 25
Stanhope, V., & Henwood, B. F. (2013) · Community Mental Health Journal · doi:10.1007/s10597-013-9686-3 · Cited by 31
Bailey, S., Gerada, C., Lester, H. E., & Shiers, D. (2012) · The Psychiatrist · doi:10.1192/pb.bp.112.039727 · Cited by 24
Breslau, J. A., Leckman‐Westin, E., Han, B., Pritam, R., Guarasi, D., Horvitz-Lennon, M. V., Scharf, D. M., Finnerty, M. T., & Yu, H. (2018) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2018.02.008 · Cited by 24
Zomer, E., Osborn, D., Nazareth, I., Blackburn, R. M., Burton, A., Hardoon, S. L., Holt, R. I. G., King, M., Marston, L., Stephen Morris, A., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-018181 · Cited by 22
Ishøy, P. L., Knop, F. K., Broberg, B. V., Baandrup, L., Fagerlund, B., Jørgensen, N. R., Andersen, U. B., Rostrup, E., Glenthoj, B. Y., & Ebdrup, B. H. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-004158 · Cited by 24
Antipsychotic-Induced Increase in Lipid Biosynthesis: Activation through Inhibition?
Skrede, S., Steen, V. M., & Fern⊘, J. (2013) · Journal of Lipid Research · doi:10.1194/jlr.e034736 · Cited by 23
Effects of psychopharmacological treatment with antidepressants on the vascular system
Kahl, K. G., Westhoff‐Bleck, M., & Krüger, T. H. C. (2017) · Vascular Pharmacology · doi:10.1016/j.vph.2017.07.004 · Cited by 25
Wang, Y., Qiu, X., Wei, Y., & Schwartz, J. D. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.029428 · Cited by 26
Chirinos, D. A., Goldberg, R. B., Llabre, M. M., Gellman, M. D., Gutt, M., McCalla, J. R., Mendez, A. J., & Schneiderman, N. (2016) · Journal of Behavioral Medicine · doi:10.1007/s10865-016-9721-2 · Cited by 23
Post, R. M., Altshuler, L. L., Leverich, G. S., Frye, M. A., Suppes, T. M., McElroy, S. L., Keck, P. E., Nolen, W. A., Kupka, R., Grunze, H., et al. (2014) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000000116 · Cited by 23
Microvascular dysfunction in schizophrenia: a case–control study
Vetter, M., Martin, B., Fung, M., Pajevic, M., Anderson, T. J., & Raedler, T. J. (2015) · Schizophrenia · doi:10.1038/npjschz.2015.23 · Cited by 24
Direct and indirect effects of psychopharmacological treatment on the cardiovascular system
Kahl, K. G. (2018) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2018-0054 · Cited by 23
Das, B., Rawat, V. S., Ramasubbu, S. K., & Kumar, B. (2019) · Therapies · doi:10.1016/j.therap.2019.03.008 · Cited by 24
Physical health problems in people with psychosis: The issue for informal carers
Onwumere, J., Howes, S., Shiers, D., & Gaughran, F. (2018) · International Journal of Social Psychiatry · doi:10.1177/0020764018763684 · Cited by 22
Daumit, G. L., Stone, E. M., Kennedy‐Hendricks, A., Pessar, S. C., Marsteller, J. A., & McGinty, E. E. (2018) · Medical Care · doi:10.1097/mlr.0000000000001023 · Cited by 22
Dalcin, A., Jerome, G. J., Appel, L. J., Dickerson, F., Wang, N., Miller, E. R., Young, D. R., Charleston, J. B., Gennusa, J. V., Goldsholl, S., et al. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00786 · Cited by 22
Bandara, S. N., Kennedy‐Hendricks, A., Stuart, E. A., Barry, C. L., Abrams, M. T., Daumit, G. L., & McGinty, E. E. (2019) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2019.12.004 · Cited by 22
Kavzoğlu, S. Ö., & Hariri, A. G. (2013) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20130713091100 · Cited by 22
Bobes, J., Alegría, A. A., Sáiz-González, M. D., Barber, I., Pérez, J. L., & Sáiz‐Ruiz, J. (2010) · European Psychiatry · doi:10.1016/j.eurpsy.2010.04.004 · Cited by 22
Towards a Healthier 2020: Advancing Mental Health as a Global Health Priority
Pike, K. M., Susser, E., Galea, S., & Pincus, H. A. (2013) · Public health reviews · doi:10.1007/bf03391692 · Cited by 22
Glucometabolic Hormones and Cardiovascular Risk Markers in Antipsychotic-Treated Patients
Ebdrup, B. H., Knop, F. K., Madsen, A., Mortensen, H. B., Søgaard, B., Holst, J. J., Szecsi, P. B., & Lublin, H. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08820 · Cited by 21
Tek, C., Gülöksüz, S., Srihari, V. H., & Reutenauer, E. L. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-176 · Cited by 21
Reverse Integration Initiatives for Individuals With Serious Mental Illness
Ward, M. C., & Druss, B. G. (2017) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20170011 · Cited by 21
The Ethics of Behavioral Health Information Technology
Joy, M. T., Clement, T., & Sisti, D. A. (2016) · JAMA · doi:10.1001/jama.2016.12534 · Cited by 21
Ho, R., Wan, A. H. Y., Au-Yeung, F. S. W., Lo, P. H. Y., Siu, P. J. C. Y., Wong, C. P. K., Ng, W. Y. H., Cheung, I. K. M., Ng, S., Chan, C., et al. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-364 · Cited by 20
Happell, B., Galletly, C. A., Castle, D. J., Platania‐Phung, C., Stanton, R., Scott, D. S., McKenna, B., Millar, F., Liu, D., Browne, M., et al. (2015) · International Journal of Mental Health Nursing · doi:10.1111/inm.12142 · Cited by 21
Fish Consumption and Heart Rate Variability
Hansen, A. L., Dahl, L., Bakke, L., Frøyland, L., & Thayer, J. F. (2010) · Journal of Psychophysiology · doi:10.1027/0269-8803/a000005 · Cited by 20
Ganguli, R., Strassnig, M., & Brar, B. (2012) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s33619 · Cited by 20
McGinty, E. E., Blasco‐Colmenares, E., Zhang, Y., dosReis, S., Ford, D. E., Steinwachs, D. M., Güallar, E., & Daumit, G. L. (2012) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2012.05.004 · Cited by 19
Preparing the workforce for integrated healthcare: A systematic review
Black, D. R. (2017) · Social Work in Health Care · doi:10.1080/00981389.2017.1371098 · Cited by 19
Relationships between IGF-1, schizophrenia, and treatment of metabolic syndrome
Demirel, A., Demirel, Ö. F., Emül, M., Duran, A., & Uğur, M. (2014) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2014.04.008 · Cited by 19
A cross sectional study of psychotropic medicine use in Australia in 2018: a focus on polypharmacy
Brett, J., Pearson, S., Daniels, B., Wylie, C. E., & Buckley, N. A. (2021) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14527 · Cited by 18
Nunes, D., Eskinazi, B., Rockett, F. C., Delgado, V. B., & Perry, I. D. S. (2014) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/j.rpsmen.2014.01.001 · Cited by 18
Measurement of Metabolic Monitoring in Youth and Adult Medicaid Recipients Prescribed Antipsychotics
Edelsohn, G. A., Parthasarathy, M., Terhorst, L. A., Karpov, I. O., & Schuster, J. (2015) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2015.21.9.769 · Cited by 21
Cardiovascular Health Issues in Inner City Populations
Nayyar, D., & Hwang, S. W. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.04.011 · Cited by 19
Arterial Stiffness in Patients Taking Second-generation Antipsychotics
Fındıklı, E., Gökçe, M., Nacitarhan, V., Camkurt, M. A., Fındıklı, H. A., Kardaş, S., Şahin, M. C., & Karaaslan, M. F. (2016) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2016.14.4.365 · Cited by 18
Physical Activity Mode and Mental Distress in Adulthood
Sciamanna, C., Smyth, J. M., Doerksen, S. E., Richard, B. R., Kraschnewski, J. L., Mowen, A. J., Hickerson, B. D., Rovniak, L. S., Lehman, E. B., & Yang, C. (2016) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2016.09.014 · Cited by 21
Mangurian, C. V., Giwa, A., Brosey, E., Shumway, M., Dilley, J., Fuentes‐Afflick, E., Pérez‐Stable, E. J., & Schillinger, D. (2019) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2019.03.180176 · Cited by 18
Ösby, U., Olsson, E., Edman, G., Hilding, A., Eriksson, S. V., & Östenson, C. G. (2013) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2013.797022 · Cited by 17
Carter, P., Rai, G., Aziz, A., Mann, J., Chandran, S., Uppal, H., & Potluri, R. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.03.116 · Cited by 17
Exercise improves physical capacity in obese patients with schizophrenia: Pilot study
Strassnig, M., Newcomer, J. W., & Harvey, P. D. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.08.011 · Cited by 17
Self-citationCancer Risk Factors Among Adults with Serious Mental Illness
Muirhead, L. (2014) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2013.10.028 · Cited by 18
Deakin, J. F. W., Ferrier, N., Holt, R. I. G., Millar, H. L., Nutt, D., Reynolds, G. P., Samani, N. J., & Taylor, D. M. (2010) · Journal of Psychopharmacology · doi:10.1177/1359786810374863 · Cited by 16
Compliance of psychotropic drug prescription with clinical practice guidelines in older inpatients
Etchepare, F., Pambrun, É., Bégaud, B., Verdoux, H., & Tournier, M. (2015) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12167 · Cited by 16
Sun, L., Getz, M., Daboul, S., Jay, M. R., Sherman, S. E., Rogers, E., Aujero, N., Rosedale, M. T., Goetz, R. R., Weissman, J. D., et al. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.01.005 · Cited by 16
Zhang, T. H., Tang, X. C., Xu, L., Yan, W., Hu, Y. G., Cui, H. R., Tang, Y. Y., Chen, T., Li, C. B., Zhou, L., et al. (2021) · Schizophrenia Bulletin · doi:10.1093/schbul/sbab080 · Cited by 16
Faghihi, T., Jahed, S. A., Mahmoudi‐Gharaei, J., Sharifi, V., Akhondzadeh, S., & Ghaeli, P. (2012) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/2008-2231-20-43 · Cited by 16
Garcia, M. E., Schillinger, D., Vittinghoff, E., Creasman, J. M., Knapp, P., Newcomer, J. W., & Mangurian, C. V. (2017) · Psychiatric Services · doi:10.1176/appi.ps.201600284 · Cited by 16
Self-citation
Metadata
- Authors
- Newcomer, J. W., & Hennekens, C. H.
- Affiliations
- Washington University in St. Louis (US)
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2007-10-17
- Volume
- 298
- Issue
- 15
- Pages
- 1794
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1966928808
- Cited by
- 433
- References
- 20
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 9 · 2023: 10 · 2022: 20 · 2021: 21 · 2020: 13 · 2019: 15 · 2018: 22 · 2017: 28 · 2016: 19 · 2015: 32 · 2014: 35 · 2013: 43 · 2012: 45
- FWCI
- 17.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (MH-72912, R01MH072912, MH63985, R01MH063985)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- severe mental illness, cardiovascular disease, cardiovascular mortality, smoking, tobacco dependence treatment, smoking cessation, premature mortality, cardiovascular risk factors, Medicaid coverage, health disparities, schizophrenia, bipolar disorder, depression
- MeSH terms
- Mental Disorders, Cardiovascular Diseases, Delivery of Health Care, Humans, Life Expectancy, Risk, United States, Needs Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review